Miriam B.
- Country
- Germany
- Department
- N/A
Research Overview
- Long-Term Safety and Tolerability of Atogepant for Migraine Prevention in Chronic or Episodic Migraine: A Phase 3, 156-Week Extension Study
- Efficacy and Safety Evaluation of Botulinum Toxin Type A in Chronic Migraine Prevention in Adults: A Randomized, Double-Blind, Placebo-Controlled Study
- Efficacy and Safety Evaluation of Clostridium Botulinum Neurotoxin Type A in Chronic Migraine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 56 of 122 partner sites.
Specializations
Migraine Management
This investigator specializes in studying advanced therapeutic approaches for chronic and episodic migraine conditions. Their research encompasses both preventive treatments and acute intervention strategies.
- Chronic Migraine Prevention
- Episodic Migraine Treatment
- Migraine Without Aura
- Migraine With Aura
Their work includes evaluation of novel therapeutic agents for migraine prevention and management.
Neurological Therapeutics
The investigator focuses on developing and assessing innovative neurological treatments, with particular attention to neurotoxin-based therapies and oral medications for headache disorders.
- Long-term Treatment Safety
- Preventive Medicine
- Therapeutic Tolerability
Their research extends to examining the consistency of therapeutic effects in migraine treatment.
Clinical Assessment
The investigator specializes in conducting comprehensive clinical evaluations of migraine treatments, focusing on both immediate and long-term therapeutic outcomes.
- Acute Treatment Efficacy
- Multiple Attack Studies
- Treatment Response Analysis
Their expertise includes analyzing monthly migraine frequency reduction and treatment effectiveness metrics.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.